Venture Life (17V) Stock Price & Analysis
17V Stock Chart & Stats
- Day’s Range
- EUR 0.78 - EUR 0.79
- 52-Week Range
- EUR 0.58 - EUR 0.83
- Previous Close
- EUR 0.78
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- EUR 96.52M
- Enterprise Value
- EUR 51.47M
- Total Cash (Recent Filing)
- EUR 34.17M
- Total Debt (Recent Filing)
- EUR 667.00K
- Price to Earnings (P/E)
- 15.6
- Beta
- 0.13
- Next Earnings
- Feb 28, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Improved Profitability
The return to positive EBIT and materially higher net income indicates stronger underlying earnings power. If maintained, improved profitability can support reinvestment, strengthen resilience, and provide greater flexibility to expand the branded healthcare portfolio.
Sharp Deleveraging
The dramatic reduction in debt substantially lowers financing risk and interest burden. A lightly leveraged balance sheet gives Venture Life more capacity to withstand operating volatility, fund product development, and pursue growth without relying heavily on external capital.
Diversified Consumer Healthcare Platform
Exposure to multiple self-care categories reduces dependence on a single product or therapeutic niche. Branded OTC products sold through pharmacies, retailers, and online channels can support recurring demand and broaden the company’s long-term distribution reach.
Bears Say
Negative Recent Cash Flow
The reversal to negative operating and free cash flow weakens confidence that reported earnings are converting consistently into cash. Persistent working-capital demands or one-off uses of cash could restrict investment capacity and reduce financial flexibility.
Volatile Revenue Trend
Large year-to-year revenue swings make demand and forecasting less predictable. This volatility can complicate inventory planning, distributor management, and cost control, while making it harder to establish a consistently compounding growth profile.
Margin And Product-Mix Pressure
Gross profit failing to rise in line with revenue suggests pressure from product mix, pricing, or costs. Unless addressed, weaker incremental margins could limit the benefit of sales growth and make future profitability more dependent on execution and portfolio optimisation.
Venture Life News
17V FAQ
What was Venture Life’s price range in the past 12 months?
What is Venture Life’s market cap?
When is Venture Life’s upcoming earnings report date?
How were Venture Life’s earnings last quarter?
Is Venture Life overvalued?
Does Venture Life pay dividends?
What is Venture Life’s EPS estimate?
How many shares outstanding does Venture Life have?
What happened to Venture Life’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Venture Life?
What is the TipRanks Smart Score and how is it calculated?
Venture Life Stock Smart Score
Company Description
Venture Life
Established in Bracknell, UK, in 2005, Venture Life Group plc is an international developer and marketer of diverse health and personal care items. The company's portfolio spans oral care products, dietary supplements, medical devices, dermo-cosmetics, and topical applications, serving a global market across the United Kingdom, various European countries (including the Netherlands, Germany, Italy, and Switzerland), and China. Operating through its distinct Venture Life Brands and Customer Brands divisions, the company offers a comprehensive array of solutions. These include advanced neurology-focused nutritional supplements such as NeuroAge, NeuroAge Sleep, and NeuroAge NRG, designed to enhance alertness, cognitive abilities, and mental acuity. For hair health, Original Bioscalin addresses hair loss, thinning, and baldness. The Myco Clear range provides antifungal nail solutions, comprising a Fungal Nail Solution for treatment and prevention, and a Fungal Nail Cleanser for foot and hand hygiene. In the realm of oral care, UltraDEX is formulated to combat bad breath, while Dently Dual Action is a mouthwash engineered to effectively remove plaque and bacteria. For anal discomfort, Procto-eze plus offers relief for conditions like haemorrhoids and general irritation. Venture Life also features a dedicated women's healthcare line under the vonalei brand, which includes a refreshing gel for bacterial vaginosis, a vaginal cream for atrophy, a soothing cream-gel for candidiasis (thrush), and an intimate cleansing foam. Its dermo-cosmetic selections encompass the Rosa calma brand's Cleansing Foam, Cleansing Cream, and Serum, alongside the Lubatti Classic and Lubatti Anti-age skincare collections. These skincare lines are meticulously crafted to hydrate, nourish, and recondition the skin, helping to minimize the appearance of lines and wrinkles. The company distributes its extensive product offerings through a broad network that includes international partners, pharmacies, and major grocery retailers.
- Sector
- Consumerdefensive
- Industry
- Medical - Pharmaceuticals
- CEO
- Jeremy Anthony Philip Randall
- Employees
- 63
- Website
- www.venture-life.com
- Address
- 12 The Courtyard, Bracknell, BR, RG12 2XB, GB
Venture Life (17V) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 17 | 4 | 1 |
| Technical Analysis | 5 | 4 | 1 |
| Moving Averages | 12 | 0 | 0 |






